<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 67-year-old gentleman presented to Yale-New Haven Hospital (YNHH) for assessment of a supratherapeutic INR and sacral lesion </plain></SENT>
<SENT sid="1" pm="."><plain>Hematologic workup revealed elevated ESR, PT, INR, PTT, and CRP, mixing studies that failed to correct, and a positive Russell Viper Venom Test (RVVT), which confirmed the presence of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LA), a subtype of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (<z:chebi fb="21" ids="53713">APA</z:chebi>) </plain></SENT>
<SENT sid="2" pm="."><plain>Pathology of the patient's sacral lesion revealed diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>This case provides insight into the association between <z:chebi fb="21" ids="53713">APA</z:chebi> and lymphoid <z:hpo ids='HP_0002664'>neoplasm</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The patient's unique presentation is in marked contrast to other reports of <z:chebi fb="21" ids="53713">APA</z:chebi> and lymphoid <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>, which are typically associated with elevated PTT, <z:mpath ids='MPATH_458'>normal</z:mpath> PT, minimal extranodal disease, and potential thrombotic complications </plain></SENT>
<SENT sid="5" pm="."><plain>Further, treatment with Rituximab-CHOP chemotherapy led to excellent clinical response with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> remission and normalization of PT and PTT </plain></SENT>
</text></document>